ADBIOTECH to issue Convertible Bonds
애드바이오텍
179530
Signal Score
Historical Avg Return (5d)
+0.72%
Data Coverage
100%n=2270
Risk-adjusted indicator based on 2270 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Early redemption rate: 103.00% (June 5, 2027) to 115.08% (March 5, 2031)
- • ETRON Co., Ltd. (Major Shareholder of target entity): Total Assets 345,611M KRW (2025)
2 more figures — Starter & Pro plans
AI Analysis Summary
ADBIOTECH Co., Ltd. has decided to issue convertible bonds. While the specific total amount, conversion price, and number of shares to be issued are not disclosed in this report, the early redemption rates range from 103.00% on June 5, 2027, to 115.08% on March 5, 2031. The report also details financial information for ETRON Co., Ltd., a major shareholder of a related entity, showing 2025 total assets of 345,611M KRW and net income of 49,460M KRW, but with a 'Disclaimer of Opinion' from its auditor. The lack of key issuance details and the auditor's opinion for a related entity suggest potential risks and dilution for existing shareholders.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.